Brave new world revisited: Focus on nanomedicine
Fadeel B, Alexiou C (2020)
Publication Type: Journal article, Review article
Publication year: 2020
Journal
DOI: 10.1016/j.bbrc.2020.08.046
Abstract
Nanomedicine is at a crossroads: with relatively few success stories in terms of clinical translation despite more and more research on increasingly sophisticated nanomaterials, it is important to consider whether we are on the right track. Indeed, it is crucial that we address the fact that while considerable efforts are being made to overcome barriers to translation from the bench to the clinic, scientists are still struggling to decipher fundamental aspects of nanomaterial interactions with biological systems. We believe that a key to the successful adoption of nanomedicines in oncology and beyond lies in a deeper understanding of underlying biological processes and in decoding interactions between engineered nanomaterials and biological systems. Here we provide an overview of progress in nanomedicine during the past 5 years.
Authors with CRIS profile
Involved external institutions
Sweden (SE)How to cite
APA:
Fadeel, B., & Alexiou, C. (2020). Brave new world revisited: Focus on nanomedicine. Biochemical and Biophysical Research Communications. https://dx.doi.org/10.1016/j.bbrc.2020.08.046
MLA:
Fadeel, Bengt, and Christoph Alexiou. "Brave new world revisited: Focus on nanomedicine." Biochemical and Biophysical Research Communications (2020).
BibTeX: Download